Advertisements

Dr.Reddy’s to sell generic version of opioid addiction treatment Suboxone in U.S.

Dr.Reddy’s to sell generic version of opioid addiction treatment Suboxone in U.S......»»

Category: topSource: the-hinduJun 15th, 2018

US court prevents Dr Reddy"s from launching opioid treatment drug Suboxone - The Hindu

US court prevents Dr Reddy"s from launching opioid treatment drug Suboxone - The Hindu.....»»

Category: topSource: googlenewsJul 14th, 2018

Indivior shares dive after Dr Reddy"s gets FDA approval for generic

Indivior shares dive after Dr Reddy"s gets FDA approval for generic.....»»

Category: global-financeSource: reutersJun 15th, 2018

Dr.Reddy"s Laboratories launches generic version of Suboxone

Dr.Reddy"s Laboratories launches generic version of Suboxone.....»»

Category: topSource: the-hinduJun 15th, 2018

US court restrains DRL"s sale of Suboxone anti-opioid copy - The Hindu

US court restrains DRL"s sale of Suboxone anti-opioid copy - The Hindu.....»»

Category: topSource: googlenewsJul 14th, 2018

Indivior wins preliminary injunction against generic rival

Indivior wins preliminary injunction against generic rival.....»»

Category: global-financeSource: reutersJul 14th, 2018

Indivior gets breather after court extends order blocking generic rival

Indivior gets breather after court extends order blocking generic rival.....»»

Category: global-financeSource: reutersJun 29th, 2018

Indivior files lawsuits against Suboxone generic rivals

Indivior files lawsuits against Suboxone generic rivals.....»»

Category: global-financeSource: reutersSep 15th, 2017

Indivior files patent lawsuits against generic Suboxone rivals

Indivior files patent lawsuits against generic Suboxone rivals.....»»

Category: global-financeSource: reutersSep 15th, 2017

Indivior says 2018 profit to fall short after U.S. market hit

Indivior says 2018 profit to fall short after U.S. market hit.....»»

Category: global-financeSource: reutersJul 11th, 2018

London-listed drugmaker Indivior shares crash after U.S. patent blow

London-listed drugmaker Indivior shares crash after U.S. patent blow.....»»

Category: global-financeSource: reutersSep 1st, 2017

London-listed drugmaker Indivior shares crash after U.S. patent blow

London-listed drugmaker Indivior shares crash after U.S. patent blow.....»»

Category: economySource: sifySep 1st, 2017

Glenmark Pharma gets USFDA nod for skin treatment cream

Glenmark Pharma gets USFDA nod for skin treatment cream.....»»

Category: topSource: the-hinduMay 11th, 2018

Glenmark Pharma gets USFDA nod for skin treatment cream

Glenmark Pharma gets USFDA nod for skin treatment cream.....»»

Category: topSource: moneycontrolMay 11th, 2018

Pharmacies may soon have separate shelf for generics

Pharmacies may soon have separate shelf for generics.....»»

Category: featuresSource: livemintMar 13th, 2018

Jubilant Pharma gets USFDA nod for Symmetrel#39;s generic version

Jubilant Pharma gets USFDA nod for Symmetrel#39;s generic version.....»»

Category: topSource: moneycontrolFeb 9th, 2018

Dr Reddy#39;s Laboratories launches Tetrabenazine tablet in US market

Dr Reddy#39;s Laboratories launches Tetrabenazine tablet in US market.....»»

Category: topSource: moneycontrolFeb 2nd, 2018

Mylan launches MS drug in US

Mylan launches MS drug in US.....»»

Category: topSource: the-hinduOct 5th, 2017

Mylan surges, Teva slumps after FDA approves Copaxone copy

Mylan surges, Teva slumps after FDA approves Copaxone copy.....»»

Category: global-financeSource: reutersOct 5th, 2017

Mylan surges, Teva slumps after FDA approves Copaxone copy

Mylan surges, Teva slumps after FDA approves Copaxone copy.....»»

Category: marketsSource: sifyOct 5th, 2017

Dr Reddy#39;s launches Sevelamer Carbonate tablets in US

Dr Reddy#39;s launches Sevelamer Carbonate tablets in US.....»»

Category: topSource: moneycontrolSep 30th, 2017